A general pattern for substrate recognition by P-glycoprotein

European Journal of Biochemistry

Volumn 251, Issue 1-2, 1998, Pages 252-261

  Seelig, Anna ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Hydrogen bonding; Multidrug resistance; P glycoprotein; Recognition pattern; Substrate recognition

Indexed keywords

ALDOSTERONE; AMIODARONE; ANESTHETIC AGENT; ANTHRACYCLINE; BISANTRENE; CARRIER PROTEIN; CEFAZOLIN; CEFOPERAZONE; CEFOTETAN; CEPHARANTHINE; CHLORPROMAZINE; CINCHONIDINE; CISPLATIN; CYCLOSPORIN; CYTOTOXIC AGENT; DACTINOMYCIN; DEXAMETHASONE; DIPYRIDAMOLE; FLUNITRAZEPAM; GALLOPAMIL; GLYCOPROTEIN P; HALOPERIDOL; LOPERAMIDE; MEPACRINE; METHADONE; PHEROMONE; PROMAZINE; TRIFLUPROMAZINE; UNINDEXED DRUG; VINCRISTINE;

ARTICLE; DRUG PROTEIN BINDING; ENZYME SPECIFICITY; HUMAN; HYDROGEN BOND; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECOGNITION;

DRUG RESISTANCE, MULTIPLE; ELECTRON TRANSPORT; MODELS, CHEMICAL; MODELS, MOLECULAR; NITROGEN; OXYGEN; P-GLYCOPROTEIN; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTRATE SPECIFICITY;

EID: 0032518454     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.1998.2510252.x     Document Type: Article

References (68)

1. Akiyama, S.-I., Cornwall, M. M., Kuwano, M., Pastan, I. & Gottesman, M. M. (1988) Most drugs that reverse multidrug resistance also inhibit photoaffinity labeling of P-glycoprotein by a Vinblastine analog, Mol. Pharmacol. 33, 144-147.
2. Azzaria, M., Schurr, E. & Gros, P. (1989) Discrete mutations introduced in the predicted nucleotide-binding site of the mdr1 gene abolishes its ability to confer multidrug resistance, Mol. Cell. Biol. 9, 5289-5297.
3. Beck, W. T., Cirtain, M. C., Glover, C. J., Felsted, R. L. & Safa, A. R. (1988) Effects of indole alkaloids on multidrug resistance and labeling of P-glycoprotein by a photoaffinity analog of vinblastine, Biochem. Biophys. Res. Commun. 153, 959-966.
4. Bhat, U. G., Winter, M. A., Pearce, H. L. & Beck, W. T. (1995) A structure-function relationship among reserpine and yohimbine analogues in their ability to increase expression of mdr1 and P-glycoprotein in a human colon carcinoma cell line, Mol. Pharmacol. 48, 682-689.
5. Board, P. G. (1993) Inhibition of erythrocyte glutathione conjugate transport by polyethoxylated surfactants, FEBS Lett. 315, 298-300.
6. Bollag, D. M., McQueney, P. A., Zhu, J., Hensens, O., Koupal, L., Liesch, J., Goetz, M., Lazarides, E. & Woods, C. M. (1995) Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action, Cancer Res. 55, 2325-2333.
7. Borst, P. & Ouelette, M. (1995) New mechanisms of drug resistance in parasitic protozoa, Annu. Rev. Microbiol. 49, 427-460.
8. Buckingham, L. E., Balasubramanian, M., Safa, A. R., Shah, H., Komarov, P., Emanuele, R. M. & Coon, J. S. (1996) Int. J. Cancer 65, 74-79.
9. Chen, C.-J., Chin, J. E., Ueda, K., Clark, D., Pastan, I., Gottesman, M. M. & Roninson, I. B. (1986) Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells, Cell 47, 381-389.
10. Chin, K. V., Tanaka, S., Darlington, G., Pastan, I. & Gottesman, M. M. (1990) Heat shock and arsenite increase expression of multidrug resistance (MDR1) gene in human renal carcinoma cells, J. Biol. Chem. 265, 221-226.
11. Cordon-Cardo, C., O'Brian, J. P., Boccia, J., Casals, D., Bertino, J. R. & Melamed, M. R. (1990a) Expression of the multidrug resistance gene product (P-glycoprotein) in human and tumor tissues, J. Histochem. Cytochem. 38, 1277-1287.
12. Cordon-Cardo, C., O'Brien, J. P., Casals, D., Rittman-Grauer, L., Biedler, J. E., Melamed, M. R. & Bertino, J. R. (1990b) Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites, Proc. Natl Acad. Sci. USA 86, 695-698.
13. Descoteaux, S., Ayala, P., Samuelson, J. & Orozco, E. (1995) Increase in mRNA of multiple Ehpgp genes encoding P-glycoprotein homologues in emetine-resistant Entamoeba histolytica parasites, Gene (Amst.) 164, 179-184.
14. Doige, C. A. & Ames, G. F.-L. (1993) ATP-dependent transport systems in bacteria and humans, relevance to cystic fibrosis and multidrug resistance, Annu. Rev. Microbiol. 47, 291-319.
15. Ferry, D. R., Traunecker, H. & Kerr, D. J. (1996) Clinical trials of P-glycoprotein reversal in solid tumors, Eur. J. Cancer 32A, 1070-1081.
16. Ford, J. M., Prozialeck, W. C. & Hait, W. N. (1988) Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance, Mol. Pharmacol. 35, 105-115.
17. Ford, J. M. (1996) Experimental reversal of P-glycoprotein-mediated multidrug resistance by pharmacological chemosensitisers, Eur. J. Cancer 32A, 991-1001.
18. Genne, P., Dimanche-Boitrel, M. T., Mauvernay, R. Y., Gutierrez, G., Duchamp, O., Petit, J.-M., Martin, F. & Chauffert, B. (1992) Cinchonine, a potent efflux inhibitor to circumvent anthracycline resistance in vivo, Cancer Res. 52, 2797-2801.
19. Germann, U. A. (1996) P-glycoprotein - mediator of multidrug resistance in tumour cells, Eur. J. Cancer 32A, 927-944.
20. Gosland, M. P., Lum, B. L. & Sikic, B. I. (1989) Reversal by cefoperazone of resistance to etoposide, doxorubicin, and vinblastine in multidrug resistant human sarcoma cells, Cancer Res. 49, 6901-6905.
21. Gosland, M., Tsuboi, C., Hoffman, T., Goodin, S. & Vore, M. (1993) 17 β-estradiol glucuronide, an inducer of cholestasis and a physiological substrate for the multidrug resistance transporter, Cancer Res. 53, 5382-5385.
22. Gottesman, M. M. & Pastan, I. (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter, Annu. Rev. Biochem. 62, 385-427.
23. Gupta, S. & Gollapudi, S. (1993) P-glycoprotein (MDR 1 gene product) in cells of the immune system, its possible physiologic role and alteration in aging and human immunodeficiency virus-1 (HIV-1) infection, J. Clin. Immunol. 13, 289-301.
24. Hait, W. N., Gesmonde, J. F., Murren, J. R., Yang, J. M., Chen, H. X. & Reiss, M. (1993) Terfenadine (Seldane), a new drug for restoring sensitivity to multidrug resistant cancer cells, Biochem. Pharmacol. 45, 401-406.
25. Higgins, C. F. (1992) ABC transporters, from microorganisms to man, Annu. Rev. Cell Biol. 8, 67-113.
26. Hsu, S. I.-H., Cohen, D., Kirschner, L. S., Lothstein, L., Hartstein, M. & Horowitz, S. B. (1990) Structural analysis of the mouse mdr1a (P-glycoprotein) promoter reveals the basis for differential transcript heterogeneity in multidrug-resistant J774.2 cells, Mol. Cell Biol. 10, 3596-3606.
27. Huwiler, J., Drewe, J., Klusemann, C. & Fricker, G. (1996) Evidence for P-glycoprotein-modulated penetration of morphine-6-glucuronide into brain capillary endothelium, Br. J. Pharmacol. 188, 1879-1885.
28. Hyafil, F., Vergely, C., Du Vignaud, P. & Grand-Perret, T. (1993) In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative, Cancer Res. 53, 4595-4602.
29. Ichikawa, M., Yoshimura, A., Sumizawa, T., Shudo, N., Kuwazuru, Y., Furukawa, T. & Akiyama, S.-I. (1991) Interaction of organic chemicals with P-glycoprotein in the adrenal gland, kidney, and a multidrug-resistant KB cell, J. Biol. Chem. 266, 903-908.
30. 939/941, Biochemistry 33, 5041-5048.
31. 3, Biochemistry 34, 4402-4411.
32. Liu, Z., Lheureux, F. Pouliot, J. F., Heckel, A., Bamberger, U. & Georges, K. (1996) BIBW22 BS, potent multidrug resistance-reversing agent, binds directly to P-glycoprotein and accumulates in drug-resistant cells, Mol. Pharmacol. 50, 482-492.
33. Liminga, G., Nygren, P. & Larsson, R. (1994) Microfluorimetric evaluation of calcein acetoxymethyl ester as a probe for P-glycoprotein-mediated resistance-effects of cyclosporin A and its nonimmunorepressive analogue SDZ PSC833, Exp. Cell Res. 212, 291-296.
34. Loe, D. W. & Sharom, F. J. (1994) Interaction of multidrug-resistant Chinese hamster ovary cells with the peptide ionophore gramicidin D, Biochim. Biophyz. Acta 1190, 72-84.
35. Marks, D. C., Su, G. M., Davey, R. A. & Davey, M. W. (1996) Extended multidrug resistance in haemopoietic cells, Br. J. Haematol. 95, 587-595.
36. McClean, S., Whelan, R. D. H., Hosking, L. K., Hodges, G. M., Thompson, F. H., Meyers, M. B., Schuurhuis, J. G. & Hill, B. T. (1993) Characterization of the P-glycoprotein over-expressing drug resistance phenotype exhibited by Chinese hamster overy cells following their in-vitro exposure to fractionated X-irradiation, Biochim. Biophys. Acta 1177, 117-126.
37. Mukhopadhyay, T., Batsakis, J. G. & Kuo, M. T. (1988) Expression of the mdr (P-glycoprotein) gene in Chinese hamster digestive tracts, J. Natl Cancer Inst. 80, 269-275.
38. Muller, C., Laval, F., Soues, S., Birck, C. & Charcosset, J. Y. (1992) High cell density-dependent resistance and P-glycoprotein-mediated multidrug resistance in mitoxantrone-selected Chinese hamster cells, Biochem. Pharmacol. 43, 2091-2102.
39. Nare, B., Prichard, R. K. & Georges, E. (1994) Characterization of rhodamine 123 binding to P-glycoprotein in human multidrug-resistant cells, Mol. Pharmacol. 45, 1145-1152.
40. Pearce, H. L., Sala, A. R., Bach, N. J., Winter, M. A., Cirtain, M. C. & Beck, W. T. (1989) Essential features of the P-glycoprotein pharmacophore as defined by a series of reserpine analogs that modulate multidrug resistance, Proc. Natl Acad Sci. USA 86, 5128-5132.
41. Piekarz, R., Cohen, D. & Horwitz, S. B. (1993) Progesterone regulates the murine multidrug resistance mdr1b gene, J. Biol. Chem. 268, 7613-7616.
42. Qian, X. D. & Beck, W. T. (1990) Progesterone photoaffinity labels P-glycoprotein in multidrug-resistant human leukemic lymphoblasts, J. Biol. Chem. 265, 18753-18756.
43. Rao, U. S., Fine, R. L. & Scarborough, G. A. (1994) Antiestrogens and steroid hormones, substrates of the human P-glycoprotein. Biochem. Pharmacol. 48, 287-292.
44. Raymond, M., Ruetz, S., Thomas, D. Y. & Gros, P. (1994) Functional expression of P-glycoprotein in Saccharomyces cerevisiae confers resistatnce to the immunosuppresive and antifungal agent FK520, Mol. Cell Biol. 14, 277-286.
45. Saeki, T. Ueda, K., Tanigawara, Y. Horni, R. & Komano, T. (1993) Human P-glycoprotein transports cyclosporin A and FK506, J. Biol. Chem. 268, 6077-6080.
46. Safa, A. R. (1993) Photoaffinity labeling of P-glycoprotein in multidrug-resistant cells, Cancer Invest. 11, 46-56.
47. 125I]iodophenethyl)spiperone binds to specific regions of P-glycoprotein and another multidrug binding protein, spiperophilin, in human neuroblastoma cells, Biochemistry 33, 256-265.
48. Safa, A. R., Roberts, S., Agresti, M. & Fine, R. L. (1994b) Tamoxyfen aziridine, a novel affinity probe for P-glycoprotein in multidrug resistant cells, Biochem. Biophys. Res. Commun. 202, 606-612.
49. Schinkel, A. H., Wagenaar, E., Mol, C. A. A. M. & van Deemter, L. (1996) P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs, J. Clin. Invest. 97, 2517-2524.
50. Schuetz, E. G., Beck, W. T. & Schuetz, J. D. (1995) Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells, Mol. Pharmacol. 49, 311-318.
51. Seelig, A., Gottschlich, R. & Devant, R. M. (1994) A method to determine the ability of drugs to diffuse through the blood-brain barrier, Proc. Natl Acad. Sci. USA 91, 68-72.
52. Shapiro, A. B. & Ling, V. (1995) Reconstitution of drug transport by purified P-glycoprotein, J. Biol. Chem. 270, 16167-16175.
53. Sharom, F. J., Yu, X. & Doige, C. A. (1993) Functional reconstitution of drug transport and ATPase activity in proteoliposomes containing partially purified P-glycoprotein, J. Biol. Chem. 268, 24197-24202.
54. Tamai, I. & Safa, A. R. (1991) Azidopine noncompetitively interacts with vinblastine and cyclosporin A binding to P-glycoprotein in multidrug resistant cells, J. Biol. Chem. 266, 16796-16800.
55. Thiebaut, F., Tsuruo, T., Hamada, H., Gottesmann, M. M., Pastan, I. & Willingham, M. C. (1987) Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues, Proc. Natl Acad. Sci. USA 84, 7735-7738.
56. Thiebaut, F., Tsuruo, T., Hamada, H., Gottesmann, M. M., Pastan, I. & Willingham, M. C. (1989) Immunohistochemical localization in normal tissues for different epitopes in the multidrug transport protein P-170, evidence for localization in brain capillaries and cross-reactivity of one antibody with a muscle protein, J. Histochem. Cytochem. 37, 159-164.
57. Thiminaiah, K. N., Horton, J. K., Quian, X.-D., Beck, W. T., Houghton, J. A. & Houghton, P. J. (1990) Structural determinants of phenoxazine type compounds required to modulate the accumulation of vinblastine and vincristine in multidrug resistant cell lines, Cancer Commun. 2, 249-259.
58. Uchiumi, T., Kohno, K., Tanimura, H., Matuso, K., Sato, S., Uchida, Y. & Kuwano, M. (1993) Enhanced expression of the human multidrug resistance 1 gene in response to UV light irradiation, Cell Growth Differ. 4, 147-157.
59. Ueda, K., Okamura, N., Hirai, M., Tanigawara, Y., Saeki, T., Kioka, N., Komano, T. & Hori, R. (1992) J. Biol. Chem. 267, 24248-24252.
60. Urbatsch, I. L., Sankaran, B., Weber, J. & Senior, A. E. (1995) P-glycoprotein is stably inhibited by vanadate-induced trapping of nucleotide at a single catalytic site, J. Biol. Chem. 270, 19383-19390.
61. Vinogradov, S. N. & Linnell, R. H. (1971) Hydrogen bonding, Van Nostrand Reinhold, New York, pp. 11-15.
62. Yusa, K. & Tsuruo, T. (1989) Reversal mechanism of multidrug resistance by verapamil, direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells, Cancer Res. 49, 5002-5006.
63. Zamora, J. M., Pearce, H. L. & Beck, W. T. (1988) Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells, Mol. Pharmacol. 33, 454-462.
64. Zhang, L., Sachs, C. W., Fine, R. L. & Casey, P. J. (1994) Interaction of prenylcysteine methyl esters with the multidrug resistance transporter, J. Biol. Chem. 269, 15973-15976.
65. Zhang, L., Sachs, C. W., Fu, H.-W., Fine, R. L. & Casey, P. J. (1995) Characterization of prenylcysteines that interact with P-glycoprotein and inhibit drug transport in tumor cells, J. Biol. Chem. 39, 22859-22865.
66. Zhang, X., Ritke, M. K., Yalowich, J. C., Slovak, M. L., Ho, J. P., Collins, K. I., Annable, T., Arceci, R. J., Durr, F. E. & Greenberger, L. M. (1994) P-glycoprotein mediates profound resistance to bisantrene, Oncol. Res. 6, 291-301.
67. Zhang, X., Collins, K. I. & Greenberger, L. M. (1995) Functional evidence that transmembrane 12 and the loop between transmembrane 11 and 12 form part of the drug-binding domain in P-glycoprotein encoded by MDR1, J. Biol. Chem. 270, 5441-5448.
68. Zordan-Nudo, T., Ling, V., Liu, Z. & Georges, E. (1993) Effects of non-ionic detergents on P-glycoprotein drug binding and reversal of multidrug resistance, Cancer Res. 53, 5994-6000.